Bristol medical devices firm FluoretiQ has launched a new initiative in the fight against AMR (antimicrobial resistance) infections, which are estimated to cause 700,000 deaths a year globally. According to research, that figure could rise to 10m – alongside a cumulative cost of $1trillion – by 2050 if no...